During the past decade, Appalachian Cardiovascular Associates conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 5 clinical trials were completed, i.e. on average, 250% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Appalachian Cardiovascular Associates" #1 sponsor was "Pfizer" with 2 trials, followed by "Abbott Medical Devices" with 1 trials sponsored, "Brigham and Women's Hospital" with 1 trials sponsored, "Idorsia Pharmaceuticals Ltd." with 1 trials sponsored and "NeuroBo Pharmaceuticals Inc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Appalachian Cardiovascular Associates" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Appalachian Cardiovascular Associates" are "Cardiovascular Disease" (3 trials), "Essential Hypertension" (1 trials), "Mixed Dyslipidaemia" (1 trials), "Optim Lead Insulation Related Adverse Events" (1 trials) and "Severe Hypertriglyceridemia" (1 trials). Many other conditions were trialed in "Appalachian Cardiovascular Associates" in a lesser frequency.

Most popular intervention types in "Appalachian Cardiovascular Associates" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "bococizumab (PF-04950615)" (2 trials), "Aprocitentan 10 mg" (1 trials), "Aprocitentan 25 mg" (1 trials) and "Aprocitentan 5 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Appalachian Cardiovascular Associates" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Appalachian Cardiovascular Associates". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Appalachian Cardiovascular Associates, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Appalachian Cardiovascular Associates, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".